Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bezafibrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bezafibrate 400mg modified-release tablets
0212000D0AAABAB
|
Bezafibrate | Bezafibrate | Cardiovascular System | 64,075 |
|
Bezafibrate 200mg tablets
0212000D0AAAAAA
|
Bezafibrate | Bezafibrate | Cardiovascular System | 13,283 |
|
Bezalip Mono 400mg modified-release tablets
0212000D0BBABAB
|
Bezalip | Bezafibrate | Cardiovascular System | 6,739 |
|
Bezalip 200mg tablets
0212000D0BBAAAA
|
Bezalip | Bezafibrate | Cardiovascular System | 470 |
|
Fibrazate XL 400mg tablets
0212000D0BFAAAB
|
Fibrazate | Bezafibrate | Cardiovascular System | 110 |
|
Lipozate 400mg modified-release tablets
0212000D0BGAAAB
|
Lipozate | Bezafibrate | Cardiovascular System | 26 |
|
Bezafibrate 200mg/5ml oral suspension
0212000D0AAACAC
|
Bezafibrate | Bezafibrate | Cardiovascular System | No data available |
|
Bezagen XL 400mg tablets
0212000D0BCAAAB
|
Bezagen | Bezafibrate | Cardiovascular System | No data available |
|
Liparol 400 XL tablets
0212000D0BDAAAB
|
Liparol | Bezafibrate | Cardiovascular System | No data available |
|
Zimbacol XL 400mg tablets
0212000D0BEAAAB
|
Zimbacol | Bezafibrate | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.